Thyroid cancer is uncommon with an estimated lifetime risk of 0.8% for women and 0.3% for
men. The incidence appears to be increasing by 4% per year and is currently the eighth …

This is the second review article on thyroid cancer dealing with the common differentiated
types that comprise 90% of thyroid cancers. Despite clinical management guidelines offered …

Conclusion Thyroid cancer comprises a group of tumors with remarkably different features.
Owing to the rising incidence of thyroid cancer and recent advances in the management of …

Objectives: Outline the epidemiology and risk factors of thyroid cancer. Describe the clinical
presentation and detailed histopathology of the different types of thyroid cancer. Explain the …

Objective: The incidence of thyroid cancer, the most common endocrine malignancy, has
increased dramatically in the last fifty years. This article will review the standard approach to …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Thyroid cancer is the most common of the endocrine malignancies and it represents< 1% of
all human tumors. The annual incidence of thyroid cancer varies considerably by …

are new to this edition. The authors provide not only the The second edition of Thyroid
Cancer: A Comp-most current review of their respective areas, but also their hensive Guide …

In view of the significant amount of work that has been carried out in the field of management
of differentiated thyroid cancer (DTC) over the last few years, members of a task force set up …

Thyroid cancer incidence is increasing, although mortality is stable. The major cause of the
increased incidence is detection of subclinical disease–overdiagnosis. Patients are still …